[Molecular pathophysiology of sideroblastic anemia]

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Sideroblastic anemias (SAs) are a group of disorders characterized by anemia and ring sideroblasts in the bone marrow.
• These anemias can be congenital (inherited) or acquired.
• Congenital sideroblastic anemia (CSA) results from genetic defects in heme biosynthesis, iron-sulfur cluster assembly, or mitochondrial protein synthesis.

Purpose of the Study:

• To review the current understanding of the molecular pathophysiology of sideroblastic anemias.
• To discuss the genetic basis of congenital forms and acquired causes of SA.
• To highlight the role of specific genes and pathways in the development of SA.

Main Methods:

• Literature review of studies on sideroblastic anemias.
• Analysis of genetic mutations associated with congenital SA, particularly X-linked sideroblastic anemia (XLSA).
• Examination of secondary causes, including drug/alcohol exposure, copper deficiency, and association with myelodysplastic syndrome (MDS).

Main Results:

• Mutations in genes like ALAS2 (involved in heme biosynthesis) are a common cause of CSA.
• Secondary SA can arise from various external factors and is often linked to myelodysplastic syndrome (idiopathic SA).
• Idiopathic SA is the most prevalent form among all SAs.

Conclusions:

• Understanding the molecular mechanisms underlying SA is crucial for diagnosis and potential therapeutic strategies.
• Genetic defects and acquired factors contribute to the heterogeneity of SA.
• Further research into SA pathophysiology may reveal new treatment targets.